Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| FAPESP 06/61388-2 | Other Grant/Funding Number | FAPESP 06/61388-2 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the study is to determine if CPAP applied within less than 15 min of life in the DR reduces the necessity of mechanical ventilation and surfactant during the first 5 days of life.
A multicenter prospective cohort of inborn preterm infants, born at 8 public university NICU in Brazil, with birthweight 1000-1499 g, without malformations, not intubated at 15 minutes of life. Preterm infants will be randomly assigned at birth to an early treatment group (DR-CPAP), in which CPAP of 5 cm water pressure is applied within 15 minutes after birth by Neopuff, or to a routine group (RG), in which CPAP is applied when indicated by the assistant physician. After transfer to the NICU, nasal CPAP will be maintained with Hudson prongs
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Routine | No Intervention | Routine protocol of the service | |
| CPAP-DR | Experimental | Infants randomized to this arm will have nasal CPAP installation at delivery room before the 15th minute of life |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CPAP | Device | CPAP of 5 cm water pressure will be applied within 15 minutes after birth by Neopuff |
|
| Measure | Description | Time Frame |
|---|---|---|
| Necessity of mechanical ventilation and surfactant during the first 5 days of life | 5 days |
| Measure | Description | Time Frame |
|---|---|---|
| Maternal and infant characteristics associated with CPAP failure during the first 15 minutes of life | 15 minutes | |
| Incidence of pneumothorax, interstitial emphysema, ductus arteriosus, peri- intra-ventricular hemorrhage, sepsis, necrotizing enterocolitis |
Not provided
Inclusion Criteria:Inborn.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Francisco E Martinez, MD | University of sao Paulo at Ribeirão Preto | Principal Investigator |
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jan 23, 2012 | |
| Reset | Feb 23, 2012 | |
| Release | Dec 2, 2014 | |
| Reset | Dec 2, 2014 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jan 23, 2012 | Feb 23, 2012 | |||
| Dec 2, 2014 |
| ID | Term |
|---|---|
| D012164 | Retinal Diseases |
| D003643 | Death |
| D012140 | Respiratory Tract Diseases |
| ID | Term |
|---|---|
| D005128 | Eye Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 30 days |
| Oxygen use | 28 days |
| Oxygen use | 56 days |
| Oxygen use | 36 weeks of corrected age |
| Retinopathies of prematurity | Hospital stay |
| Death during hospitalization | Hospital stay |
| Dec 2, 2014 |